Untitled Document
CRCCases
  About prIME Oncology Cases in Colorectal Cancer
 
prIME Oncology invites you to participate in our prIME Cases in Colorectal Cancer series; a CME-certified series of 6 case studies, each with an expert perspective from internationally renowned thought leaders in colorectal cancer. Participants will be able to vote on their preferred therapy choice(s) and view the aggregate, real-time results of their peers’ choices.
 
Treatment of First-Line Metastatic Colorectal Cancer

Treatment of First-Line Metastatic Colorectal Cancer

Herbert Hurwitz, MD, and Yousuf Zafar, MD, MHS
Duke University Medical Center
Durham, North Carolina, United States
Treatment of Early-Stage Colorectal Cancer: Adjuvant Therapy Decision-Making

Treatment of Early-Stage Colorectal Cancer: Adjuvant Therapy Decision-Making

Axel Grothey, MD
Mayo Clinic
Rochester, Minnesota, United States
Second-Line Therapy for Metastatic Colorectal Cancer

Second-Line Therapy for Metastatic Colorectal Cancer

David Kerr, MD, DSc
University of Oxford
Oxford, United Kingdom
Improving Patient Outcomes: Monitoring and Managing Adverse Events in Patients with Colorectal Cancer

Improving Patient Outcomes: Monitoring and Managing Adverse Events in Patients with Colorectal Cancer


Edith P. Mitchell, MD, FACP
Kimmel Cancer Center at Jefferson
Thomas Jefferson University
Philadelphia, Pennsylvania, United States

 
A. Bevacizumab-Induced Hypertension
B. EGFR Inhibitor–Induced Dermatologic Toxicities
C. Oxaliplatin-Induced Neuropathy